4.88 USD
↗ 0.42 (9.42%)AT CLOSE (11:59 AM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
4.94
↗ 0.06 (1.23%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
4.94
↗ 0.06 (1.23%)
Market: CLOSED
Open?$4.74
High?$5.02
Low?$4.63
Prev. Close?$4.46
Volume?6.5M
Avg. Volume?6.5M
VWAP?$4.90
Rel. Volume?1.01x
Bid / Ask
Bid?$4.91 × 100
Ask?$4.93 × 1.9K
Spread?$0.02
Midpoint?$4.92
Valuation & Ratios
Market Cap?900.5M
Shares Out?184.5M
Float?147.9M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?12.71
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.70Strong
Quick Ratio?10.70Strong
Cash Ratio?10.23Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?12.71HIGH▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-29.3CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.9%WEAK▾
ROA?-34.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$828.7M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Employees
13
Market Cap
823.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278